Atrial fibrillation in heart failure: High mortality risk even if ventricular function is preserved

American Heart Journal

Volumn 150, Issue 4, 2005, Pages 701-706

  Parkash, Ratika ^a   Maisel, William H ^b   Toca, F Michael ^b   Stevenson, William G ^b  

^a QUEEN ELIZABETH II HEALTH SCIENCES CENTRE   (Canada)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

AGED; ANAMNESIS; AORTA VALVE DISEASE; ARTICLE; CANCER; CEREBROVASCULAR DISEASE; CREATININE BLOOD LEVEL; DATA ANALYSIS; DISEASE ASSOCIATION; EMERGENCY WARD; FEMALE; GROUPS BY AGE; HEART ATRIUM FIBRILLATION; HEART EJECTION FRACTION; HEART FAILURE; HEART INFARCTION; HEART VENTRICLE FUNCTION; HUMAN; HYPERTENSION; LUNG DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE ANALYSIS; PATIENT; PRIORITY JOURNAL; PROGNOSIS; SODIUM BLOOD LEVEL;

AGED; ATRIAL FIBRILLATION; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; MALE; PROGNOSIS; RISK FACTORS; VENTRICULAR FUNCTION, LEFT;

EID: 25844513871     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ahj.2004.12.014     Document Type: Article

References (32)

1. W.A. Wattigney, G.A. Mensah, and J.B. Croft Increasing trends in hospitalization for atrial fibrillation in the United States, 1985 through 1999: implications for primary prevention Circulation 108 2003 711 716
2. E.J. Benjamin, D. Levy, and S.M. Vaziri Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study JAMA 271 1994 840 844
3. American Heart Association Heart disease and stroke statistics-2004 update 2003 American Heart Association Dallas (Tex)
4. H. Tsutsui Mortality and readmission of hospitalized patients with congestive heart failure and preserved versus depressed systolic function Am J Cardiol 88 2001 530 533
5. M.M. Redfield Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic JAMA 289 2003 194 202
6. L.P. Badano, M.C. Albanese, and P. De Biaggio Prevalence, clinical characteristics, quality of life, and prognosis of patients with congestive heart failure and isolated left ventricular diastolic dysfunction J Am Soc Echocardiogr 17 2004 253 261
7. R.S. Vasan, M.G. Larson, and E.J. Benjamin Congestive heart failure in subjects with normal versus reduced left ventricular ejection fraction: prevalence and mortality in a population-based cohort J Am Coll Cardiol 33 1999 1948 1955
8. D.L. Dries, D.V. Exner, and B.J. Gersh Atrial fibrillation is associated with an increased risk for mortality and heart failure progression in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: a retrospective analysis of the SOLVD trials. Studies of Left Ventricular Dysfunction J Am Coll Cardiol 32 1998 695 703
9. P.E. Carson, G.R. Johnson, and W.B. Dunkman The influence of atrial fibrillation on prognosis in mild to moderate heart failure. The V-HeFT Studies. The V-HeFT VA Cooperative Studies Group Circulation 87 Suppl 6 1993 VI102 VI110
10. P.A. Wolf, R.D. Abbott, and W.B. Kannel Atrial fibrillation as an independent risk factor for stroke: the Framingham Study Stroke 22 1991 983 988
11. M. Pozzoli, G. Cioffi, and E. Traversi Predictors of primary atrial fibrillation and concomitant clinical and hemodynamic changes in patients with chronic heart failure: a prospective study in 344 patients with baseline sinus rhythm J Am Coll Cardiol 32 1998 197 204
12. G. Cioffi, M. Pozzoli, and G. Forni Systemic thromboembolism in chronic heart failure. A prospective study in 406 patients Eur Heart J 17 1996 1381 1389
13. T.S. Tsang, B.J. Gersh, and C.P. Appleton Left ventricular diastolic dysfunction as a predictor of the first diagnosed nonvalvular atrial fibrillation in 840 elderly men and women J Am Coll Cardiol 40 2002 1636 1644
14. M. Klapholz, M. Maurer, and A.M. Lowe Hospitalization for heart failure in the presence of a normal left ventricular ejection fraction: results of the New York Heart Failure Registry J Am Coll Cardiol 43 2004 1432 1438
15. P.A. McKee, W.P. Castelli, and P.M. McNamara The natural history of congestive heart failure: the Framingham study N Engl J Med 285 1971 1441 1446
16. H.R. Middlekauff, W.G. Stevenson, and L.W. Stevenson Prognostic significance of atrial fibrillation in advanced heart failure. A study of 390 patients Circulation 84 1991 40 48
17. T.J. Wang, M.G. Larson, and D. Levy Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: the Framingham Heart Study Circulation 107 2003 2920 2925
18. F. Gustafsson, C. Torp-Pedersen, and B. Brendorp Long-term survival in patients hospitalized with congestive heart failure: relation to preserved and reduced left ventricular systolic function Eur Heart J 24 2003 863 870
19. H. Tsutsui, M. Tsuchihashi, and A. Takeshita Mortality and readmission of hospitalized patients with congestive heart failure and preserved versus depressed systolic function Am J Cardiol 88 2001 530 533
20. O.D. Pedersen, H. Bagger, and L. Kober Trandolapril reduces the incidence of atrial fibrillation after acute myocardial infarction in patients with left ventricular dysfunction Circulation 100 1999 376 380
21. A.H. Madrid, C. Escobar, and J.M. Rebollo Angiotensin receptor blocker as adjunctive therapy for rhythm control in atrial fibrillation: results of the irbesartan-amiodarone trial Card Electrophysiol Rev 7 2003 243 246
22. D. Li, K. Shinagawa, and L. Pang Effects of angiotensin-converting enzyme inhibition on the development of the atrial fibrillation substrate in dogs with ventricular tachypacing-induced congestive heart failure Circulation 104 2001 2608 2614
23. S. Yusuf, M.A. Pfeffer, and K. Swedberg Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial Lancet 362 2003 777 781
24. J.N. Cohn, and G. Tognoni A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure N Engl J Med 345 2001 1667 1675
25. S.D. Corley, A.E. Epstein, and J.P. DiMarco Relationships between sinus rhythm, treatment, and survival in the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Study Circulation 109 2004 1509 1513
26. Scandinavian Simvastatin Survival Study Group Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S) Lancet 344 1994 1383 1389
27. Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. N Engl J Med 339 1998 1349 1357
28. F.M. Sacks, M.A. Pfeffer, and L.A. Moye The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators N Engl J Med 335 1996 1001 1009
29. Y. Young-Xu, S. Jabbour, and R. Goldberg Usefulness of statin drugs in protecting against atrial fibrillation in patients with coronary artery disease Am J Cardiol 92 2003 1379 1383
30. C.W. Siu, C.P. Lau, and H.F. Tse Prevention of atrial fibrillation recurrence by statin therapy in patients with lone atrial fibrillation after successful cardioversion Am J Cardiol 92 2003 1343 1345
31. A. Shiroshita-Takeshita, G. Schram, and J. Lavoie Effect of simvastatin and antioxidant vitamins on atrial fibrillation promotion by atrial-tachycardia remodeling in dogs Circulation 110 2004 2313 2319
32. K. Kalantar-Zadeh, G. Block, and T. Horwich Reverse epidemiology of conventional cardiovascular risk factors in patients with chronic heart failure J Am Coll Cardiol 43 2004 1439 1444